nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—DDC—telencephalic ventricle—brain cancer	0.0612	0.102	CbGeAlD
Droxidopa—DDC—pineal body—brain cancer	0.0531	0.0884	CbGeAlD
Droxidopa—DDC—ganglion—brain cancer	0.0381	0.0635	CbGeAlD
Droxidopa—DDC—hindbrain—brain cancer	0.0289	0.0481	CbGeAlD
Droxidopa—SLC6A2—ganglion—brain cancer	0.0182	0.0302	CbGeAlD
Droxidopa—DDC—brainstem—brain cancer	0.0166	0.0276	CbGeAlD
Droxidopa—PAH—endocrine gland—brain cancer	0.0163	0.0271	CbGeAlD
Droxidopa—PAH—head—brain cancer	0.0161	0.0267	CbGeAlD
Droxidopa—DDC—telencephalon—brain cancer	0.0147	0.0245	CbGeAlD
Droxidopa—PAH—central nervous system—brain cancer	0.0147	0.0244	CbGeAlD
Droxidopa—ADRA1A—hindbrain—brain cancer	0.0128	0.0213	CbGeAlD
Droxidopa—PAH—brain—brain cancer	0.0116	0.0194	CbGeAlD
Droxidopa—ADRA1D—telencephalon—brain cancer	0.0113	0.0189	CbGeAlD
Droxidopa—DDC—midbrain—brain cancer	0.0106	0.0176	CbGeAlD
Droxidopa—DDC—endocrine gland—brain cancer	0.00927	0.0154	CbGeAlD
Droxidopa—DDC—head—brain cancer	0.00915	0.0152	CbGeAlD
Droxidopa—SLC16A10—gonad—brain cancer	0.00841	0.014	CbGeAlD
Droxidopa—DDC—central nervous system—brain cancer	0.00836	0.0139	CbGeAlD
Droxidopa—ADRB1—telencephalon—brain cancer	0.00823	0.0137	CbGeAlD
Droxidopa—SLC6A2—brainstem—brain cancer	0.00789	0.0131	CbGeAlD
Droxidopa—ADRA1A—brainstem—brain cancer	0.00734	0.0122	CbGeAlD
Droxidopa—ADRA1B—head—brain cancer	0.00722	0.012	CbGeAlD
Droxidopa—ADRA1D—endocrine gland—brain cancer	0.00715	0.0119	CbGeAlD
Droxidopa—ADRA1D—head—brain cancer	0.00706	0.0118	CbGeAlD
Droxidopa—SLC6A2—telencephalon—brain cancer	0.007	0.0117	CbGeAlD
Droxidopa—DDC—brain—brain cancer	0.00663	0.011	CbGeAlD
Droxidopa—ADRA1B—central nervous system—brain cancer	0.00659	0.011	CbGeAlD
Droxidopa—ADRA1A—telencephalon—brain cancer	0.00651	0.0108	CbGeAlD
Droxidopa—ADRA1D—central nervous system—brain cancer	0.00644	0.0107	CbGeAlD
Droxidopa—SLC16A10—endocrine gland—brain cancer	0.00636	0.0106	CbGeAlD
Droxidopa—ADRA2C—telencephalon—brain cancer	0.0062	0.0103	CbGeAlD
Droxidopa—SLC6A2—gonad—brain cancer	0.00584	0.00973	CbGeAlD
Droxidopa—SLC16A10—cerebellum—brain cancer	0.0056	0.00933	CbGeAlD
Droxidopa—SLC6A2—medulla oblongata—brain cancer	0.0055	0.00916	CbGeAlD
Droxidopa—ADRA1B—brain—brain cancer	0.00523	0.00871	CbGeAlD
Droxidopa—ADRB1—endocrine gland—brain cancer	0.00519	0.00865	CbGeAlD
Droxidopa—ADRB1—head—brain cancer	0.00513	0.00854	CbGeAlD
Droxidopa—ADRA1D—brain—brain cancer	0.00512	0.00852	CbGeAlD
Droxidopa—ADRA2C—pituitary gland—brain cancer	0.00505	0.00841	CbGeAlD
Droxidopa—ADRA2A—telencephalon—brain cancer	0.00495	0.00824	CbGeAlD
Droxidopa—ADRA2C—medulla oblongata—brain cancer	0.00487	0.00812	CbGeAlD
Droxidopa—ADRB1—central nervous system—brain cancer	0.00468	0.00779	CbGeAlD
Droxidopa—ADRA2C—midbrain—brain cancer	0.00446	0.00742	CbGeAlD
Droxidopa—SLC6A2—endocrine gland—brain cancer	0.00442	0.00735	CbGeAlD
Droxidopa—SLC6A2—head—brain cancer	0.00436	0.00726	CbGeAlD
Droxidopa—ADRA2C—spinal cord—brain cancer	0.00435	0.00724	CbGeAlD
Droxidopa—ADRA2A—gonad—brain cancer	0.00413	0.00688	CbGeAlD
Droxidopa—Dopamine—CYP2C9—brain cancer	0.00413	0.506	CrCbGaD
Droxidopa—ADRA1A—endocrine gland—brain cancer	0.00411	0.00684	CbGeAlD
Droxidopa—ADRA1A—head—brain cancer	0.00405	0.00675	CbGeAlD
Droxidopa—Epinephrine—CYP2C9—brain cancer	0.00403	0.494	CrCbGaD
Droxidopa—ADRA2A—pituitary gland—brain cancer	0.00403	0.00671	CbGeAlD
Droxidopa—SLC6A2—central nervous system—brain cancer	0.00398	0.00663	CbGeAlD
Droxidopa—ADRA2A—medulla oblongata—brain cancer	0.00389	0.00648	CbGeAlD
Droxidopa—ADRA2C—head—brain cancer	0.00386	0.00643	CbGeAlD
Droxidopa—ADRB1—brain—brain cancer	0.00372	0.00619	CbGeAlD
Droxidopa—ADRA1A—central nervous system—brain cancer	0.0037	0.00616	CbGeAlD
Droxidopa—ADRA1A—cerebellum—brain cancer	0.00362	0.00602	CbGeAlD
Droxidopa—ADRA2A—midbrain—brain cancer	0.00355	0.00592	CbGeAlD
Droxidopa—ADRA2C—central nervous system—brain cancer	0.00353	0.00587	CbGeAlD
Droxidopa—ADRA2A—spinal cord—brain cancer	0.00347	0.00578	CbGeAlD
Droxidopa—ADRA2C—cerebellum—brain cancer	0.00345	0.00574	CbGeAlD
Droxidopa—SLC6A2—brain—brain cancer	0.00316	0.00526	CbGeAlD
Droxidopa—ADRA2A—endocrine gland—brain cancer	0.00312	0.0052	CbGeAlD
Droxidopa—ADRA2A—head—brain cancer	0.00308	0.00513	CbGeAlD
Droxidopa—ADRA1A—brain—brain cancer	0.00294	0.00489	CbGeAlD
Droxidopa—ADRA2A—central nervous system—brain cancer	0.00281	0.00468	CbGeAlD
Droxidopa—ADRA2C—brain—brain cancer	0.0028	0.00466	CbGeAlD
Droxidopa—ADRA2A—cerebellum—brain cancer	0.00275	0.00458	CbGeAlD
Droxidopa—ADRA2A—brain—brain cancer	0.00223	0.00372	CbGeAlD
Droxidopa—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	0.000179	0.000458	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SHH—brain cancer	0.000177	0.000452	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PDGFRA—brain cancer	0.000176	0.000451	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SHH—brain cancer	0.000175	0.000448	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—VAV1—brain cancer	0.000175	0.000447	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SUFU—brain cancer	0.000174	0.000446	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SHH—brain cancer	0.000173	0.000442	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HEY1—brain cancer	0.000172	0.000439	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SPP1—brain cancer	0.000171	0.000437	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TRPC6—brain cancer	0.000171	0.000436	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TRPC6—brain cancer	0.000169	0.000432	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—DLL1—brain cancer	0.000168	0.00043	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GFAP—brain cancer	0.000168	0.00043	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SMO—brain cancer	0.000168	0.000428	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTCH1—brain cancer	0.000168	0.000428	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IL2—brain cancer	0.000167	0.000426	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TRPC6—brain cancer	0.000167	0.000426	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SMO—brain cancer	0.000166	0.000425	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTCH1—brain cancer	0.000166	0.000425	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	0.000166	0.000424	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SMO—brain cancer	0.000164	0.000419	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTCH1—brain cancer	0.000164	0.000419	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SHH—brain cancer	0.000164	0.000418	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL2—brain cancer	0.000163	0.000416	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—VAV1—brain cancer	0.000163	0.000416	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SHH—brain cancer	0.000161	0.000412	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HEY1—brain cancer	0.000159	0.000407	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ENO2—brain cancer	0.000159	0.000406	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TRPC6—brain cancer	0.000158	0.000403	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—DLL1—brain cancer	0.000156	0.0004	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IL2—brain cancer	0.000156	0.000398	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TRPC6—brain cancer	0.000155	0.000397	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTCH1—brain cancer	0.000155	0.000397	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SMO—brain cancer	0.000155	0.000397	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IRS2—brain cancer	0.000155	0.000396	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTCH1—brain cancer	0.000153	0.00039	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SMO—brain cancer	0.000153	0.00039	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	0.000151	0.000387	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	0.000151	0.000385	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	0.00015	0.000383	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	0.000148	0.000378	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	0.000147	0.000376	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SHH—brain cancer	0.000143	0.000366	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—VEGFA—brain cancer	0.000142	0.000362	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VAV1—brain cancer	0.00014	0.000358	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	0.00014	0.000358	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TRPC6—brain cancer	0.000138	0.000353	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	0.000138	0.000352	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	0.000137	0.000351	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—APC—brain cancer	0.000137	0.000349	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PIK3CG—brain cancer	0.000137	0.000349	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	0.000136	0.000348	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SMO—brain cancer	0.000136	0.000347	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTCH1—brain cancer	0.000136	0.000347	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	0.000134	0.000343	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOTCH2—brain cancer	0.000134	0.000343	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SHH—brain cancer	0.000133	0.00034	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	0.000133	0.000339	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—VEGFA—brain cancer	0.000132	0.000339	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOTCH2—brain cancer	0.000131	0.000335	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TRPC6—brain cancer	0.000128	0.000328	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VAV1—brain cancer	0.000128	0.000327	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	0.000127	0.000325	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VAV1—brain cancer	0.000127	0.000324	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL2—brain cancer	0.000127	0.000324	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTCH1—brain cancer	0.000126	0.000322	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SMO—brain cancer	0.000126	0.000322	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	0.000125	0.00032	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VAV1—brain cancer	0.000125	0.000319	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—EGFR—brain cancer	0.000125	0.000318	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	0.000124	0.000317	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	0.000122	0.000313	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	0.000122	0.000312	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HES1—brain cancer	0.000121	0.000308	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VAV1—brain cancer	0.000118	0.000302	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL2—brain cancer	0.000117	0.000299	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VAV1—brain cancer	0.000116	0.000297	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	0.000115	0.000293	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	0.000114	0.000291	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SPP1—brain cancer	0.000111	0.000285	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	0.000111	0.000284	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HES1—brain cancer	0.00011	0.000281	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HES1—brain cancer	0.000109	0.000278	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	0.000108	0.000277	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—VEGFA—brain cancer	0.000108	0.000275	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HES1—brain cancer	0.000107	0.000275	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—brain cancer	0.000107	0.000274	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RELA—brain cancer	0.000107	0.000273	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL2—brain cancer	0.000106	0.000272	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ERBB2—brain cancer	0.000106	0.000271	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL2—brain cancer	0.000106	0.000271	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL2—brain cancer	0.000105	0.000269	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PDGFRA—brain cancer	0.000105	0.000267	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL2—brain cancer	0.000104	0.000266	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	0.000104	0.000265	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VAV1—brain cancer	0.000103	0.000264	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	0.000103	0.000264	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PDGFRA—brain cancer	0.000102	0.000262	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HES1—brain cancer	0.000102	0.00026	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SPP1—brain cancer	0.000102	0.00026	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IRS2—brain cancer	0.000101	0.000258	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	0.000101	0.000258	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SPP1—brain cancer	0.000101	0.000257	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HES1—brain cancer	0.0001	0.000256	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—brain cancer	0.0001	0.000256	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SPP1—brain cancer	9.94e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2—brain cancer	9.85e-05	0.000252	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2—brain cancer	9.69e-05	0.000248	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	9.68e-05	0.000247	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2—brain cancer	9.66e-05	0.000247	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2—brain cancer	9.62e-05	0.000246	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VAV1—brain cancer	9.6e-05	0.000245	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2—brain cancer	9.58e-05	0.000245	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	9.53e-05	0.000244	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2—brain cancer	9.45e-05	0.000242	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SPP1—brain cancer	9.4e-05	0.00024	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCND1—brain cancer	9.38e-05	0.00024	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CTNNB1—brain cancer	9.29e-05	0.000237	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SPP1—brain cancer	9.25e-05	0.000236	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IRS2—brain cancer	9.19e-05	0.000235	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IRS2—brain cancer	9.1e-05	0.000233	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IRS2—brain cancer	8.99e-05	0.00023	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PIK3CG—brain cancer	8.98e-05	0.00023	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2—brain cancer	8.94e-05	0.000229	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	8.9e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—APC—brain cancer	8.9e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HES1—brain cancer	8.89e-05	0.000227	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2—brain cancer	8.8e-05	0.000225	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2—brain cancer	8.61e-05	0.00022	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IRS2—brain cancer	8.5e-05	0.000217	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	8.47e-05	0.000216	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IRS2—brain cancer	8.37e-05	0.000214	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HES1—brain cancer	8.26e-05	0.000211	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SPP1—brain cancer	8.22e-05	0.00021	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—VEGFA—brain cancer	8.17e-05	0.000209	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—brain cancer	8.13e-05	0.000208	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—APC—brain cancer	8.11e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PIK3CG—brain cancer	8.11e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—brain cancer	8.11e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—STAT3—brain cancer	8.09e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—APC—brain cancer	8.04e-05	0.000205	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	8.04e-05	0.000205	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2—brain cancer	8e-05	0.000204	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—APC—brain cancer	7.94e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PIK3CG—brain cancer	7.94e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	7.87e-05	0.000201	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2—brain cancer	7.82e-05	0.0002	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SPP1—brain cancer	7.64e-05	0.000195	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MYC—brain cancer	7.52e-05	0.000192	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—APC—brain cancer	7.51e-05	0.000192	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	7.51e-05	0.000192	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IRS2—brain cancer	7.43e-05	0.00019	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—brain cancer	7.39e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—APC—brain cancer	7.39e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	7.39e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—brain cancer	7.36e-05	0.000188	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—brain cancer	7.32e-05	0.000187	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PIK3CG—brain cancer	7.29e-05	0.000186	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2—brain cancer	7.27e-05	0.000186	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—brain cancer	7.23e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RELA—brain cancer	6.96e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ERBB2—brain cancer	6.91e-05	0.000177	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IRS2—brain cancer	6.91e-05	0.000176	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—brain cancer	6.84e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—brain cancer	6.73e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APC—brain cancer	6.56e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	6.56e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RELA—brain cancer	6.34e-05	0.000162	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ERBB2—brain cancer	6.3e-05	0.000161	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RELA—brain cancer	6.28e-05	0.000161	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2—brain cancer	6.27e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ERBB2—brain cancer	6.24e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RELA—brain cancer	6.2e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—brain cancer	6.18e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ERBB2—brain cancer	6.16e-05	0.000157	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCND1—brain cancer	6.11e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APC—brain cancer	6.1e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	6.1e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	6.05e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—brain cancer	5.98e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RELA—brain cancer	5.87e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ERBB2—brain cancer	5.83e-05	0.000149	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RELA—brain cancer	5.77e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ERBB2—brain cancer	5.74e-05	0.000147	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—brain cancer	5.71e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—brain cancer	5.66e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—brain cancer	5.58e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCND1—brain cancer	5.57e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—brain cancer	5.56e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCND1—brain cancer	5.51e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CTNNB1—brain cancer	5.51e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	5.46e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCND1—brain cancer	5.44e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CTNNB1—brain cancer	5.39e-05	0.000138	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—brain cancer	5.32e-05	0.000136	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—brain cancer	5.28e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—brain cancer	5.27e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—brain cancer	5.2e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCND1—brain cancer	5.15e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RELA—brain cancer	5.13e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	5.1e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ERBB2—brain cancer	5.1e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCND1—brain cancer	5.07e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	5.02e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MYC—brain cancer	4.9e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—brain cancer	4.85e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—brain cancer	4.81e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—brain cancer	4.8e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—brain cancer	4.79e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RELA—brain cancer	4.77e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—brain cancer	4.76e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—brain cancer	4.75e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ERBB2—brain cancer	4.74e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—brain cancer	4.7e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—brain cancer	4.62e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCND1—brain cancer	4.5e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—brain cancer	4.49e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MYC—brain cancer	4.46e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	4.46e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—brain cancer	4.45e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MYC—brain cancer	4.42e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—brain cancer	4.42e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—brain cancer	4.38e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MYC—brain cancer	4.37e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—brain cancer	4.37e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—brain cancer	4.33e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—brain cancer	4.29e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—brain cancer	4.27e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCND1—brain cancer	4.18e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	4.14e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MYC—brain cancer	4.13e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MYC—brain cancer	4.07e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—brain cancer	4.04e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—brain cancer	4.02e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.98e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.93e-05	0.0001	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.89e-05	9.93e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—brain cancer	3.67e-05	9.37e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.65e-05	9.32e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—brain cancer	3.63e-05	9.28e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MYC—brain cancer	3.61e-05	9.23e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.61e-05	9.23e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—brain cancer	3.59e-05	9.17e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.53e-05	9.03e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—brain cancer	3.39e-05	8.67e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MYC—brain cancer	3.36e-05	8.58e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—brain cancer	3.34e-05	8.53e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—brain cancer	3.28e-05	8.39e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—brain cancer	2.97e-05	7.58e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—brain cancer	2.76e-05	7.04e-05	CbGpPWpGaD
